Gene Therapy - Table of Contents alert Volume 24 Issue 7

If you are unable to see the message below, click here to view.

Advertisement TECHNICAL NOTE: Why is AAV one of the most promising viral gene transfer vectors?  AAV vectors provide promising gene delivery vehicles in large scale preclinical productions for target identification/validation studies, or used in large animal models and clinical trials of human gene therapy. The technical note explores: Achieving preclinical efficacy Basic systems for growing cells in culture Use of bioreactors Read technical note TABLE OF CONTENTS Volume 24, Issue 7 (July 2017) In this issue Reviews Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Twitter Facebook Instagram Advertisement REGENERATION 2017 Presented by: Ospedale San Raffaele | Nature The conference will feature sessions on regeneration in animal models, functional and dysfunctional regeneration in mammals, and new therapeutic approaches to regeneration. November 16-18, 2017 | Milan, Italy REGISTER NOW! Reviews Top Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS Z Huang, A Tomitaka, A Raymond and M Nair Gene Ther 2017 24: 377-384; advance online publication, June 1, 2017; 10.1038/gt.2017.35 Abstract | Full Text Herpesvirus microRNAs for use in gene therapy immune-evasion strategies S T F Bots and R C Hoeben Gene Ther 2017 24: 385-391; advance online publication, May 9, 2017; 10.1038/gt.2017.37 Abstract | Full Text Original Articles Top INSR gene polymorphisms correlate with sensitivity to platinum-based chemotherapy and prognosis in patients with epithelial ovarian cancer J-L Hu, X-L Hu, Q Han, A-Y Guo, C-J Wang, Y-Y Wen and S-D Cang Gene Ther 2017 24: 392-398; advance online publication, April 24, 2017; 10.1038/gt.2017.26 Abstract | Full Text SOST silencing promotes proliferation and invasion and reduces apoptosis of retinoblastoma cells by activating Wnt/β-catenin signaling pathway T Wu, L-N Wang, D-R Tang and F-Y Sun Gene Ther 2017 24: 399-407; advance online publication, June 15, 2017; 10.1038/gt.2017.31 Abstract | Full Text Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation Y Sun, S Peng, A Yang, E Farmer, T-C Wu and C-F Hung Gene Ther 2017 24: 408-415; advance online publication, May 11, 2017; 10.1038/gt.2017.38 Abstract | Full Text Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle J P Gomez, C Gonçalves, C Pichon and P Midoux Gene Ther 2017 24: 416-424; advance online publication, May 15, 2017; 10.1038/gt.2017.40 Abstract | Full Text CD34+ cells from dental pulp stem cells with a ZFN-mediated and homology-driven repair-mediated locus-specific knock-in of an artificial β-globin gene S Chattong, O Ruangwattanasuk, W Yindeedej, A Setpakdee and K Manotham Gene Ther 2017 24: 425-432; advance online publication, May 22, 2017; 10.1038/gt.2017.42 Abstract | Full Text Synergistic effects of deleting multiple nonessential elements in nonreplicative HSV-1 BAC genomic vectors play a critical role in their viability M Ventosa, A Ortiz-Temprano, H Khalique and F Lim Gene Ther 2017 24: 433-440; advance online publication, May 29, 2017; 10.1038/gt.2017.43 Abstract | Full Text Advertisement A new open access journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine. Part of the Nature Partner Journals series, the journal is published in partnership with the Center of Excellence in Genomic Medicine Research.  Open for submissions >>  Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.